YB:NASDAQYuanbao Inc. Analysis
Data as of 2026-05-28 - not real-time
$13.54
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Yuanbao Inc. (YB) trades at a trailing P/E of 3.35, dramatically below the software industry average of 40.37, indicating deep undervaluation. The company posted $4.37 bn in revenue with 32% YoY growth, and its gross margin of 96% and operating margin of 34% underscore an exceptionally profitable model. Cash on hand exceeds $3.96 bn while debt is negligible, yielding a debt‑to‑equity of 0.24 and a ROE of 51%, suggesting a strong balance sheet. Earnings per share are projected to rise from $4.04 to $4.92, reinforcing the growth narrative. The price‑to‑sales ratio of 0.14 and a price‑to‑book of 1.27 further highlight the cheapness relative to peers. Together, these fundamentals paint a picture of a high‑quality, growth‑oriented business trading at a discount.
Conversely, the stock is caught in a bearish technical environment, with the price ($13.54) sitting below the 20‑day (14.79), 50‑day (16.68) and 200‑day (20.32) moving averages, an RSI of 36, and a MACD histogram in negative territory, suggesting short‑term downside pressure. Volatility is elevated at 58.8% over the past 30 days and beta exceeds 1.1, amplifying market risk, while daily volume is thin (≈459 shares) relative to its 10‑day average of 40 k, raising liquidity concerns. The company operates in China’s tightly regulated insurance brokerage sector, exposing it to high regulatory and geographic risk. Despite these headwinds, the market sentiment index is at 92 (Extreme Greed), indicating investor appetite that could support a rebound. In summary, while the fundamentals are compelling, investors should weigh the technical weakness, high volatility, and regulatory backdrop when timing entry.
Conversely, the stock is caught in a bearish technical environment, with the price ($13.54) sitting below the 20‑day (14.79), 50‑day (16.68) and 200‑day (20.32) moving averages, an RSI of 36, and a MACD histogram in negative territory, suggesting short‑term downside pressure. Volatility is elevated at 58.8% over the past 30 days and beta exceeds 1.1, amplifying market risk, while daily volume is thin (≈459 shares) relative to its 10‑day average of 40 k, raising liquidity concerns. The company operates in China’s tightly regulated insurance brokerage sector, exposing it to high regulatory and geographic risk. Despite these headwinds, the market sentiment index is at 92 (Extreme Greed), indicating investor appetite that could support a rebound. In summary, while the fundamentals are compelling, investors should weigh the technical weakness, high volatility, and regulatory backdrop when timing entry.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish technical indicators (price below all SMAs, negative MACD)
- Thin daily trading volume increasing liquidity risk
- Proximity to recent support level at $12.01
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong earnings growth and high ROE/ROA
- Extremely low P/E relative to industry peers
- Robust cash position with minimal debt
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustained revenue expansion and high profit margins
- Market mispricing reflected in low price‑to‑sales and price‑to‑book ratios
- Potential upside as regulatory environment stabilizes
Key Metrics & Analysis
Financial Health
Revenue Growth32.20%
Profit Margin29.90%
P/E Ratio3.4
ROE50.94%
ROA22.47%
Debt/Equity0.24
P/B Ratio1.3
Op. Cash Flow$1.5B
Free Cash Flow$969.8M
Industry P/E40.4
Technical Analysis
TrendBearish
RSI36.3
Support$12.01
Resistance$16.98
MA 20$14.79
MA 50$16.68
MA 200$20.32
MACDBearish
VolumeIncreasing
Fear & Greed Index92.09
Valuation
Fair Value$842.56
Target Price$22.11
Upside/Downside63.30%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta1.18
Volatility58.84%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.